CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase I/II Safety, Dose Finding and Feasibility Trial of MB-CART20.1 in Patients with Relapsed or Resistant CD20 Positive B-NHL
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03664635
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:07.257765+00:00
- Published At
- 2024-11-21T00:00:00+00:00
- Record Updated At
- 2024-11-21
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Relapsed or Refractory B-cell Non-Hodgkin\u0027s Lymphoma", "Non-Hodgkin\u0027s Lymphoma", "B-cell Lymphoma Refractory", "B-cell Lymphoma Recurrent"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-11-21"- protocolSection.identificationModule.nctId
"NCT03664635"- protocolSection.identificationModule.officialTitle
"A Phase I/II Safety, Dose Finding and Feasibility Trial of MB-CART20.1 in Patients with Relapsed or Resistant CD20 Positive B-NHL"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.